These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
329 related articles for article (PubMed ID: 7049376)
1. Asparaginase and amino acids in cancer therapeutics. Cancer and Leukemia Group B Investigators. Holland JF; Ohnuma T Cancer Treat Rep; 1981; 65 Suppl 4():123-30. PubMed ID: 7049376 [TBL] [Abstract][Full Text] [Related]
2. L-Asparaginase, vincristine, and prednisone for induction of first remission in acute lymphocytic leukemia. Ortega JA; Nesbit ME; Donaldson MH; Hittle RE; Weiner J; Karon M; Hammond D Cancer Res; 1977 Feb; 37(2):535-40. PubMed ID: 264412 [TBL] [Abstract][Full Text] [Related]
3. [Letter: Acute lymphoid leukemia: constant induction of remission by the combination of prednisone, vincristine and L-asparaginase (20 cases)]. Mathe G; Pouillart P; De Vassal F; Delgado M; Schwarzenberg L; Misset JL; Hayat M; Jasmin C; Belpomme D; Musset M Nouv Presse Med; 1976 Jun; 5(23):1491. PubMed ID: 1064849 [No Abstract] [Full Text] [Related]
4. Minimal residual disease (MRD) measurement as a tool to compare the efficacy of chemotherapeutic drug regimens using Escherichia Coli-asparaginase or Erwinia-asparaginase in childhood acute lymphoblastic leukemia (ALL). Kwok CS; Kham SK; Ariffin H; Lin HP; Quah TC; Yeoh AE Pediatr Blood Cancer; 2006 Sep; 47(3):299-304. PubMed ID: 16302217 [TBL] [Abstract][Full Text] [Related]
5. Effective dose of L-asparaginase for induction of remission in previously treated children with acute lymphocytic leukemia: a report from Childrens Cancer Study Group. Ertel IJ; Nesbit ME; Hammond D; Weiner J; Sather H Cancer Res; 1979 Oct; 39(10):3893-6. PubMed ID: 383278 [TBL] [Abstract][Full Text] [Related]
6. L-Asparaginase as a single agent in acute lymphocytic leukemia: survey of studies form Childrens Cancer Study Group. Nesbit ME; Ertel I; Hammond GD Cancer Treat Rep; 1981; 65 Suppl 4():101-7. PubMed ID: 7049373 [TBL] [Abstract][Full Text] [Related]
7. Asparaginase in combination chemotherapy for remission induction of childhood acute lymphocytic leukemia. Pratt CB; Roberts D; Shanks E; Warmath EL; Jackson R Cancer Res; 1973 Sep; 33(9):2020-5. PubMed ID: 4516498 [No Abstract] [Full Text] [Related]
8. Pharmacokinetics and drug monitoring of L-asparaginase treatment. Boos J Int J Clin Pharmacol Ther; 1997 Mar; 35(3):96-8. PubMed ID: 9088996 [TBL] [Abstract][Full Text] [Related]
9. [Preliminary results of the clinical study of a Soviet--produced L-asparaginase from E. coli]. Kondrat'eva NA; Lorie IlI ; Kruglova GV; Vorob'ev AI; Koshel' IV Antibiotiki; 1977 Sep; 22(9):852-7. PubMed ID: 334060 [No Abstract] [Full Text] [Related]
10. Erwinia carotovora asparaginase in patients with prior anaphylaxis to asparaginase from E. coli. Ohnuma T; Holland JF; Meyer P Cancer; 1972 Aug; 30(2):376-81. PubMed ID: 4559405 [No Abstract] [Full Text] [Related]
11. Asparaginase: molecular and enzymic requirements for use as an antileukaemia agent. Wade HE J Gen Microbiol; 1971 Mar; 65(3):x-xi. PubMed ID: 4997395 [No Abstract] [Full Text] [Related]
12. Clinical evaluation of succinylated Acinetobacter glutaminase-asparaginase in adult leukemia. Warrell RP; Arlin ZA; Gee TS; Chou TC; Roberts J; Young CW Cancer Treat Rep; 1982 Jul; 66(7):1479-85. PubMed ID: 7046929 [TBL] [Abstract][Full Text] [Related]
13. Optimal current treatment of childhood acute lymphoblastic leukemia. Simone JV Cancer Treat Rep; 1981; 65 Suppl 4():97-100. PubMed ID: 7049384 [TBL] [Abstract][Full Text] [Related]
14. A comparative study of the antitumor effectiveness of E. coli and Erwinia asparaginases. Roberts J; Schmid FA; Old LJ; Stockert E Cancer Biochem Biophys; 1976 May; 1(4):175-8. PubMed ID: 788892 [TBL] [Abstract][Full Text] [Related]
15. Abnormal glucose tolerance in children with acute leukemia. Effect of induction chemotherapy including L-asparaginase. Dacou-Voutetakis C; Palis J; Haidas S; Zannos-Mariolea L; Georgiopoulou P; Matsaniotis N Am J Pediatr Hematol Oncol; 1983; 5(2):139-46. PubMed ID: 6351658 [TBL] [Abstract][Full Text] [Related]
16. Biochemical and pharmacological studies with asparaginase in man. Ohnuma T; Holland JF; Freeman A; Sinks LF Cancer Res; 1970 Sep; 30(9):2297-305. PubMed ID: 4920133 [No Abstract] [Full Text] [Related]
17. Vincristine and prednisone vs vincristine, L-asparaginase, and prednisone for second remission induction of acute lymphocytic leukemia in children. Herson J; Starling KA; Dyment PG; Humphrey GB; Pullen J; Vats T Med Pediatr Oncol; 1979; 6(4):317-23. PubMed ID: 384187 [TBL] [Abstract][Full Text] [Related]
18. An isocratic fluorescence HPLC assay for the monitoring of l-asparaginase activity and l-asparagine depletion in children receiving E. colil-asparaginase for the treatment of acute lymphoblastic leukaemia. Nath CE; Dallapozza L; Eslick AE; Misra A; Carr D; Earl JW Biomed Chromatogr; 2009 Feb; 23(2):152-9. PubMed ID: 18823071 [TBL] [Abstract][Full Text] [Related]
19. Modified pharmacokinetics of I-asparaginase from E coli by formation of specific antibodies to I-Asparaginase of different immunoglobulin classes in children with acute lymphocytic leukemia. Wahn V; Fabry U; Körholz D; Reinhardt D; Jürgens H; Göbel U Pediatr Pharmacol (New York); 1983; 3(3-4):303-11. PubMed ID: 6377216 [TBL] [Abstract][Full Text] [Related]
20. Antibody formation during intravenous and intramuscular therapy with Erwinia asparaginase. Albertsen BK; Schrøder H; Jakobsen P; Avramis VI; Müller HJ; Schmiegelow K; Carlsen NT Med Pediatr Oncol; 2002 May; 38(5):310-6. PubMed ID: 11979454 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]